| 摘要 |
An inclusion complex of naproxen or a pharmaceutically salt thereof such as naproxen sodium, an unsubstituted or substituted beta-cyclodextrin such as 2-hydroxypropyl-beta-cyclodextrin, and a hydroxylamine such as tromethamine, wherein in the complex, naproxen or the pharmaceutically acceptable salt thereof is included in the beta-cyclodextrin and the hydroxylamine interacts with both naproxen or the pharmaceutically acceptable salt thereof and the beta-cyclodextrin, is useful as a pharmaceutical product. |
